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NMR spectroscopyRecent reports which show that several chemokines can act as direct microbicidal agents have drawn
renewed attention to these chemotactic signalling proteins. Here we present a structure–function analysis of
peptides derived from the human chemokines macrophage inﬂammatory protein-3α (MIP-3α/CCL20),
interleukin-8 (IL-8), neutrophil activating protein-2 (NAP-2) and thrombocidin-1 (TC-1). These peptides
encompass the C-terminal α-helices of these chemokines, which have been suggested to be important for
the direct antimicrobial activities. Far-UV CD spectroscopy showed that the peptides are unstructured in
aqueous solution and that a membrane mimetic solvent is required to induce a helical secondary structure. A
co-solvent mixture was used to determine solution structures of the peptides by two-dimensional 1H-NMR
spectroscopy. The highly cationic peptide, MIP-3α51–70, had the most pronounced antimicrobial activity and
displayed an amphipathic structure. A shorter version of this peptide, MIP-3α59–70, remained antimicrobial
but its structure and mechanism of action were unlike that of the former peptide. The NAP-2 and TC-1
proteins differ in their sequences only by the deletion of two C-terminal residues in TC-1, but intact TC-1 is a
very potent antimicrobial while NAP-2 is inactive. The corresponding C-terminal peptides, NAP-250–70 and
TC-150–68, had very limited and no bactericidal activity, respectively. This suggests that other regions of TC-1
contribute to its bactericidal activity. Altogether, this work provides a rational structural basis for the
biological activities of these peptides and proteins and highlights the importance of experimental
characterization of peptide fragments as distinct entities because their activities and structural properties
may differ substantially from their parent proteins.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides and chemokines were originally thought to
have distinct roles in the innate immune response. The former are
identiﬁed through their direct interactions with and killing actions on
invading microbes and the latter through their role in inducing
leukocyte trafﬁcking. However, these two groups of secreted
molecules share many common properties although they have
different primary sequences [1–4]. As host-defense molecules of the
immune system, the expression levels of defensins and chemokines
can be upregulated together in response to microbial challenges [5,6].
Most importantly, there is some overlap in function as some defensins
are now known to be capable of activating speciﬁc chemokine
receptors [2,7,8]. Conversely, many chemokines have recently been
shown to exhibit direct antimicrobial activity [9–11]. Like conven-
tional antimicrobial peptides, these chemokines have net positive
charges with pI's greater than 9.0. A structural survey indicated that+1 403 289 9311.
ll rights reserved.large positively charged patches on the molecular surface are a
common theme found in antimicrobial chemokines, but not in
nonantimicrobial chemokines [10]. Peptide cationicity favors inter-
actions with negatively charged moieties on the surface of microbial
membranes over zwitterionic mammalian membranes [12]. The best
documented example of an antimicrobial chemokine is the human
macrophage inﬂammatory protein-3α (MIP-3α), also known as CC
chemokine ligand 20 (CCL20) [10,13]. MIP-3α is active at low
effective concentrations against a wide range of organisms, including
Gram-positive and Gram-negative bacterial species, as well as fungi
[10]. Against Escherichia coli, the chemokine is more potent than
several human β-defensins. Similar to defensins and many other
antimicrobial peptides, this activity is salt-sensitive, which suggests
that charge interactions play a major role in the activity [14,15]. Of all
the chemokines, MIP-3α is functionally linked to the β-defensins
through their ability to activate the CC chemokine receptor-6 (CCR6)
[16,17], which is otherwise rather speciﬁc and does not interact with
any other chemokines [18,19].
In tumor progression, the chemotactic activity of MIP-3α can be
inactivated by cathepsin D proteolytic processing [20]. This process
releases a 12-aa C-terminal peptide fragment of MIP-3α that can act
Table 1
Naturally isolated C-terminal truncation products of the chemokines MIP-3α, IL-8 and
NAP-2 and their antimicrobial activities.
Peptide Sequence Antimicrobial activitiesa Ref.
MIP-3α/
CCL20
ASNFDCCLGY TDKILHPKFI
VGRTRQLANE GCDINAIIFH
TKKKLSVCAN PKQTWVKYIV
RLLSKKVKNM
E. coli,
S. aureus,
P. aeruginosa,
M. catarrhalis,
S. pyogenes,
E. faecium,
C. albicans,
C. neoformans
[10]
CCL201–66 ASNFDCCLGY TDKILHPKFI
VGRTRQLANE GCDINAIIFH
TKKKLSVCAN PKQTWVKYIV
RLLSKK
E. coli [20]
CCL2059–70 IVRLLSKKVK NM E. coli [20]
IL-8 SAKELRCQCI KTYSKPFHPK
FIKELRVIES GPHCANTEII
VKLSDGRELC LDPKENWVQR
VVEKFLKRAE NS
S. typhimurium, low
activity for E. coli, S.
aureus and C. albicans
[10,
31,
32]
hIL-8
C-peptide
CLDPKENWVQ RVVEKFLKRA ENS - [85]
NAP-2 AELRCMCIKT TSGIHPKNIQ
SLEVIGKGTH CNQVEVIATL
KDGRKICLDP DAPRIKKIVQ
KKLAGDESAD
No activity [35]
NAP-2
(1–66)
AELRCMCIKT TSGIHPKNIQ
SLEVIGKGTH CNQVEVIATL
KDGRKICLDP DAPRIKKIVQ KKLAGD
- [34]
NAP-2
(1–63)
AELRCMCIKT TSGIHPKNIQ
SLEVIGKGTH CNQVEVIATL
KDGRKICLDP DAPRIKKIVQ KKL
- [37]
TC-1 AELRCMCIKT TSGIHPKNIQ
SLEVIGKGTH CNQVEVIATL
KDGRKICLDP DAPRIKKIVQ
KKLAGDES
B. subtilis,
E. coli,
S. aureus,
L. lactis,
C. neoformans
[35]
a Peptides for which no antimicrobial data has been reported are indicated by a dash.
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the ﬁrst 55 residues of the 70-aa MIP-3α protein, is inactive against
bacteria. The antimicrobial region is part of the C-terminal α-helix in
MIP-3α that begins at Thr54. This α-helix is highly amphipathic with
large aliphatic and aromatic sidechains making hydrophobic contacts
with residues of the antiparallel β-sheet and positively charged
sidechains facing the exterior of the protein [21,22]. A peptide
corresponding to the entire α-helix and its ﬂanking residues is
unstructured in aqueous solution, but adopts the native secondary
structure in membrane mimetic environments [21]. This behavior is
characteristic of most members of the α-helical class of antimicrobial
peptides such as the magainins and cecropins [23,24] and has also
been observed with lactoferrampin, another cationic antimicrobial
peptide derived from a large protein [25,26]. Further work shows that
some α-helical antimicrobial peptides can adopt helix-break-helix
structures [27], helical hairpins upon complexation with LPS [28], or
antiparallel dimers or higher oligomeric states to help penetrate
membranes [29,30].
Another cationic CXC chemokine, interleukin-8 (IL-8), has mild to
nonexistent antimicrobial activity depending on the assay conditions
used and the bacterium tested. IL-8 is generally inactive against E. coli
and Staphylococcus aureus but it is inhibitory against Salmonella
typhimurium [10,31,32]. Interestingly, peptide fragments encompass-
ing the C-terminal α-helix of IL-8 are more potent as antimicrobials
compared to the parent protein, most notably against E. coli in solid-
state andwhole blood assays [31,32]. This suggests that the remainder
of the IL-8 protein may obstruct the full antimicrobial potential of this
segment.
The far C-terminal region is also important in the CXC chemokine
neutrophil-activating protein-2 (NAP-2), which is known to bind the
same chemokine receptor as IL-8 [33]. NAP-2 is isolated from human
platelets and the intact protein displays low antimicrobial activity. A
NAP-2 variant with a two-residue C-terminal truncation has been
isolated and the resulting product not only exhibits higher neutrophil-
stimulating capacity [34], but it is also highly bactericidal and
fungicidal [35]. The activity of this product, named thrombocidin-1
(TC-1), again highlights the importance of the C-terminal region of
chemokines for microbicidal activity. TC-1 has been found to be an
important host defence factor in human platelets against infective
endocarditis due to Viridans streptococci [36]. Products of more
extensive C-terminal truncations of NAP-2 have previously been
discovered in vivo, although their consequence for antimicrobial
activity is unknown at present [34,37]. Isolated products of C-terminal
processing of MIP-3α, IL-8 and NAP-2 are shown in Table 1 with
available antimicrobial activity data.
In this work, we have used NMR and CD spectroscopy to
characterize the structures of peptides corresponding to the C-
terminal α-helical regions of MIP-3α, IL-8, NAP-2 and TC-1. Their
biological activities were measured; moreover vesicle leakage assays
were performed by ﬂuorescence spectroscopy to investigate their
mode of action. These structure–function analyses allow us to explore
these isolated chemokine fragments as potential future antibiotics
and provide insight into their role in the overall microbicidal
properties of the parent chemokines.
2. Materials and methods
All the synthetic peptides were obtained at N95% purity from 21st
Century Biochemicals (Marlboro, MA). The concentrations of MIP-
3α51–70 and IL-853–72 were calculated by UV absorption at 280 nm
using extinction coefﬁcients determined by ProtParam [38]. The
concentrations of the peptides without aromatic sidechains, MIP-
3α59–70, NAP-250–70 and TC-150–68, were determined by weight. All
lipids (chicken egg L-α-phosphatidylcholine, ePC; chicken egg L-α-
phosphatidylglycerol, ePG; cholesterol) and the lipid extrusion
apparatus were purchased from Avanti Polar Lipids (Alabaster, AL).2.1. CD spectroscopy
The peptides' secondary structures were estimated by circular
dichroism (CD) spectroscopy in the far UV range (185–260 nm).
Spectra for each sample were recorded on a J-810 spectropolarimeter
(Jasco, Tokyo, Japan) at a scanning rate of 200 nm/min, 1 nm band
width, 0.5 nm resolution. Ten scans were accumulated and averaged
for each sample. 10 μM peptide was used in each sample using water
and different concentrations of TFE in % v/v as solvent, going from 0%
to 70% TFE in increments of 10%. Mean residue molar ellipticities, [θ],
in deg cm2 dmol−1 were calculated using the formula: [θ]=[θ]obs /
10ncd where [θ]obs is the experimentally measure ellipticity in
milllideg, n is the number of residues, c is the molar peptide
concentration, and d is the optical pathlength of the cell in cm. All
CD spectra were acquired at room temperature and analyzed for α-
helical content by curve ﬁtting using the SELCON 3 program [39,40] of
the CD Pro software package (http://lamar.colostate.edu/∼sreeram/
CDPro). Data from 50 proteins, including 13 membrane proteins, was
used as the reference set for curve ﬁtting of the spectra.
2.2. NMR spectroscopy and structure calculations
For NMR samples, ∼2 mg of peptide was dissolved in 500 μL of
4:4:1 CD3OH:CDCl3:H2O, except for MIP-3α59–70 which was dissolved
in a 100-fold excess of SDS micelles. Two-dimensional NOESY, TOCSY,
and DQF-COSY spectra were acquired for each peptide at 25 °C on
Bruker Avance 600 and 700 MHz spectrometers (Bio-NMR Center,
University of Calgary, Alberta, Canada). The 700 MHz spectrometer is
equipped with a triple resonance inverse cryoprobe with single axis
z-gradient. 2048×600 complex data points were acquired for the
Table 2
Sequences and net charges of the C-terminal chemokine peptides.
Peptide Sequence Net charge % helicitya
MIP-3α51–70 PKQTWVKYIVRLLSKKVKNM +6 3.9
MIP-3α59–70 IVRLLSKKVKNM +4 0.3
IL-853–72 PKENWVQRVVEKFLKRAENS +2 1.5
NAP-250–70 PDAPRIKKIVQKKLAGDESAD +1 1.3
TC-150–68 PDAPRIKKIVQKKLAGDES +2 1.3
a As predicted by AGADIR [54,55] based on the amino acid sequence.
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250 ms and 120 ms except for the MIP-3α59–70 sample in SDS
micelles, which had respective mixing times of 100 ms and 80 ms.
The DQF-COSY spectra were acquired with 4096×512 complex data
points. The spectral sweep widths were 10 ppm. Solvent suppression
was achieved using excitation sculpting [41], and the methanol signal
was used as a chemical shift reference. Spectra were processed using
NMRPipe [42].
The NMRView 5.0.4 software package [43] was used for spectral
analysis. Resonance assignment was achieved by standard methods
[44]. The program ARIA 1.2 [45,46] was used for structure calcula-
tions. In addition to the meaningful inter- and intra-residue nOe's,
broad Φ dihedral angle restraints between −35° and −175° were
used for non-Pro and non-Gly residues. Default parameters were used
in each ARIA run, however in the last two iterations of the last run the
numbers of structures calculated were increased from 20 to 40 and
150. The 20 lowest energy structures of the last iterations were
retained and their dihedral angles were analyzed using Procheck 3.2
[47]. Structures were visualized using MOLMOL [48]. Hydrophobic
moments (μH) of the α-helices were calculated from the Totalizer
module of MPEx (http://blanco.biomol.uci.edu/mpex) which uses
the experimentally based interfacial Wimley–White hydrophobicity
scales [49].
2.3. Bactericidal assays
The peptides were tested for microbicidal activities against Bacillus
subtilis ATCC6633, E. coli ML35, and S. aureus 42D as previously
described [21,43]. Suspensions of logarithmically growing test
bacteria were incubated in a microtiter plate at a concentration of
105 colony-forming units/mL with peptides in serial 2-fold dilutions.
The total incubation volume was 100 μL, using 10 mM phosphate
buffer pH 7.0 supplemented with 1% (v/v) of tryptic soy broth (TSB).
At time 0 h and after 2 h of incubation on a rotary shaker (300 rpm) at
37 °C, 10 μL aliquots were collected and plated on blood agar plates
and incubated overnight at 37 °C. The concentration of peptide
eliminating all growth, killing N99.9% of the inoculum, at 2 h is the
99.9% Lethal Dose (LD99.9). These experiments were performed in
duplicate.
2.4. Hemolytic assays
Hemolytic activity was tested using fresh human red blood cells.
Blood collected in EDTA was added to PBS (10 mM phosphate
buffer, 130 mM NaCl, pH 7.4) and centrifuged at 200×g for 15 min.
The upper layer of pelleted cells was removed, leaving a pellet
enriched in erythrocytes. These cells were washed three times in
PBS and 1% suspensions (v/v) were prepared in this buffer. Serial
dilutions of peptides were prepared in 0.01% acetic acid in a
polypropylene microtiter plate (Costar, Cambridge, USA). To 5 μL of
diluted peptide, 45 μL of the erythrocyte suspensions were added.
Incubations without peptide and with 1% Triton X-100 served as
negative and positive controls, respectively. Mixtures were incu-
bated at 37 °C for 60 min and subsequently centrifuged at 1000×g
for 5 min. The supernatant was transferred to a new microtiter
plate and hemoglobin was measured spectrophotometrically at
540 nm. Hemolysis was expressed as a percentage of hemolysis of
the 1% Triton X-100 positive control. Experiments were performed
in quadruplicate.
2.5. Calcein leakage
A standard calcein leakage assay [50] was performed using
preparations of large unilamellar vesicles (LUVs) composed of 1:1
ePC:ePG and 2.5:1 ePC:cholesterol to represent bacterial and
mammalian membranes, respectively [51]. Films were formed inglass vials by evaporation from stock aliquots of the appropriate lipids.
The lipid ﬁlms were suspended by vortexing in leakage buffer (10mM
Tris, 150 mM NaCl, 1 mM EDTA, pH 7.4) containing 70 mM calcein,
after which vesicles were formed by ﬁve freeze-thaw cycles. Finished
LUVs were made by extrusion through two stacked 0.1 μm polycar-
bonate ﬁlters (Nucleopore Filtration Products, Pleasanton, CA) using a
Mini-Extruder (Avanti Polar Lipids, Alabaster, AL) with a minimum of
11 passes [52]. The Ames phosphate assay was used to determine the
concentrations of phospholipids in the ﬁnished products [53].
Calcein leakage experiments were performed in triplicate on a
Varian Cary Eclipse ﬂuorimeter with excitation and emission
wavelengths of 490 nm and 520 nm, and excitation and emission
slit widths of 5 nm. Measurements were carried out in a 1-mL sample
volume with mixing and kept at 37 °C using a Peltier temperature
control device. Calcein-encapsulated LUVs were diluted in leakage
buffer to a ﬁnal phospholipid concentration of 10 μM. The calcein-
loaded LUVs were supplemented by LUVs prepared in calcein-free
leakage buffer to increase lipid concentrations for studies of peptide to
lipid molar ratios (P/L). Using the kinetics application in the Cary
Eclipse software package, the baseline ﬂuorescencewasmonitored for
1 min (Fo), after which peptide was added to a ﬁnal concentration of
1 μM. After the addition of peptide the increase in ﬂuorescence due to
the release of the calcein dye from the vesicles (F) was monitored for
10 min. In cases where low levels of leakage were observed, further
assays at lower peptide to lipid ratios were not pursued. The total
calcein ﬂuorescence (FT) was determined by the addition of Triton
X-100 to a ﬁnal concentration of 0.1%.
3. Results
3.1. Initial peptide design
After analyzing the sequences and three-dimensional structures of
the four chemokines, a common Pro residue was chosen as the
starting point for the C-terminalα-helix peptides. In all four cases, this
residue is at the start of the turn connecting the β-sheet to the
carboxy-terminal α-helix. Because of its unique cyclic structure, a Pro
residue can also be advantageous as it would protect against exo-
proteolytic degradation at the N-terminus. The subsequent residues of
the chemokines make up the remainder of the peptides, resulting in
sequences that are 19–21 residues in length. The peptides were
named according to the corresponding residue numbers of the parent
chemokines: MIP-3α51–70, IL-853–72, NAP-250–70, and TC-150–68. The
resulting IL-8-derived sequence coincides with a fragment recovered
after acid hydrolysis [31]. The previously studied 12-residue peptide,
MIP-3α59–70 [20], was also included for comparisonwithMIP-3α51–70.
Amino acid sequences of the peptides and some sequence-based
properties are found in Table 2.
3.2. α-Helical content prediction in aqueous solution
The C-terminal chemokine peptides were analyzed for their α-
helical propensity by AGADIR (Table 2) [54,55]. AGADIR is a fast and
reliable computational method for predicting the α-helical content of
isolated monomeric peptides in aqueous solution, taking into account
Fig. 1. Far-UV circular dichroism spectra of the C-terminal chemokine peptides in (A)
water and (B) 40% TFE. (C) % α-helicity of the peptides at various concentrations of TFE
estimated by curve-ﬁtting with the SELCON 3 program [39,40]. The reference set used
for curve ﬁtting is based on protein data and therefore % α-helicity values are
approximate for the peptides studied here. Spectra were acquired at ambient
temperature, and the plots for the peptides (10 μM) are as follows: MIP-3α51–70,
solid black; MIP-3α59–70, black short dashes; IL-853–72, long dashes; NAP-250–70, solid
gray; TC-150–68, gray short dashes.
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chain–sidechain interactions andmain-chain to main-chain hydrogen
bonds. The algorithm is generally used to evaluate peptide domains
that have been isolated from larger proteins [56,57]. Therefore,
AGADIR presents a tool for unbiased structure prediction of peptides
independent of their conformation in the parent protein. The
predicted α-helical contents in the peptides are consistently low
with the highest proportion being 3.9% for MIP-3α51–70 and the
lowest value belonging to the shortest peptide, MIP-3α59–70. Hence,
these peptides likely do not retain their native secondary structures in
aqueous solution. This is in agreement with AGADIR values calculated
for canonical antimicrobial peptides such as magainin-2 (0.4%) that
are known to require a membranous or membrane-mimetic environ-
ment to fold into α-helices [23,24,58].
3.3. Circular dichroism spectroscopy
Far-UV CD spectra were acquired at room temperature to
investigate the secondary structures of the C-terminal peptides
(Fig. 1). In aqueous solution (Fig. 1A), the majority of the peptides had
no speciﬁc backbone conformation, in agreement with the predictions
calculated by the AGADIR program. The lack of structure in water for
IL-853–72 disagrees with previously reported CD spectroscopy data
presented for a very similar peptide that lacked the N-terminal Pro
residue that suggested stable α-helical conformation in aqueous
buffer [32]. Spectra were also acquired for IL-853–72 under the same
experimental conditions used in the earlier study (0.1 mM peptide,
10.0 mM sodium phosphate, pH 5.5) and the expected proﬁle
characteristic of random coil structure was once again observed
(Supplementary Fig. 1).
CD spectra of these peptides were also acquired in the presence of
increasing concentrations of the co-solvent 2,2,2-triﬂuoroethanol
(TFE). TFE/water mixtures are often used to determine the α-helical
propensity of peptides. Moreover they are sometimes used for
structural studies of antimicrobial peptides as membrane mimetic
solvents and they have been found to exert the same structural
inﬂuence on the peptides as the addition of sodium dodecyl sulfate
(SDS) or dodecylphosphocholine (DPC) micelles [59,60]. Triﬂuor-
oethanol is also widely used as a cosolvent to induce α-helical
structure in other peptides and proteins [61]. As the TFE content
increased, the random coil signature for the ﬁve chemokine peptides
quickly disappeared and an increase in α-helical content was
observed with the typical double minima at 208 and 222 nm.
Representative scans of the peptides in 40% TFE are shown in Fig. 1B.
The method SELCON3 [39,40] was used for the analysis of the α-
helical content of the chemokine peptides (Fig. 1C). The reference set
used for curve ﬁtting included 50 proteins, 13 of which were
membrane proteins. Because this did not include any peptides, % α-
helicity values are approximate. For TFE concentrations increasing
from 0% up to 40%, the helicities of the peptides increased until they
reach near maximal levels. MIP-3α51–70 in particular had a stronger
α-helical propensity than the other peptides, as its helicity increased
sharply at a lower TFE concentration, and it had considerably higher
α-helical content compared to the other peptides. The α-helicities of
the other chemokine peptides increased marginally beyond 40% TFE
and the α-helicity of the shorter MIP3α59–70 displays the most
shallow change with increasing TFE concentrations (Fig. 1C).
3.4. NMR structure determination
Due to the lack of regular structure of the C-terminal peptides in
aqueous solution, a membrane-mimetic solvent was utilized for
detailed structural analysis by NMR spectroscopy. Traditional 2D 1H
TOCSY and NOESY NMR spectra were acquired for the C-terminal
chemokine peptides at 25 °C dissolved in a mixture of 4:4:1
chloroform:methanol:water. This organic co-solvent system haspreviously been used to mimic membrane systems in NMR studies
of membrane proteins and peptides [62–64]. The NOESY spectrum of
MIP-3α51–70 in this co-solvent shows better deﬁned correlations
compared to previously acquired spectra of the same peptide bound
to SDS micelles (Supplementary Fig. 2) [21]. This is due to the higher
effective molecular weight of the micelle/peptide complexes, result-
ing in broadened signal linewidths. Therefore, the use of the nonpolar
solvent mixture, which also has a lower viscosity, improves the
quality of the spectra and facilitates the peak assignments and
subsequent structure calculations. The NOESY for MIP-3α59–70 in
4:4:1 chloroform:methanol:water, however, did not give enough
peaks for proper assignments, and therefore its structure was
calculated in the membrane-mimetic environment of SDS micelles.
Table 3
Structural statistics for the twenty ﬁnal NMR structures of the C-terminal chemokine
peptides.
MIP-
3α51–70
MIP-
3α59–70
IL-
853–72
NAP-
250–70
TC-
150–68
No. of distance restraints
Unambiguous NOEs 300 227 247 308 345
Ambiguous NOEs 81 17 66 25 18
Total NOEs 381 244 313 333 363
Broad dihedral restraints 17 10 13 16 14
Global RMSDs
Backbone (Å) 0.849 0.729 2.128 1.547 1.359
Heavy atom (Å) 1.541 1.386 2.702 2.233 1.927
α-helix RMSDsa
Backbone (Å) 0.407 – 0.436 0.364 0.449
Heavy atom (Å) 1.057 – 1.099 1.123 1.057
α-helix RMSDs vs. full chemokinesb
Backbone (Å) 0.61 – 0.65 0.57 0.69
Heavy atom (Å) 1.58 – 1.61 1.69 1.68
Ramachandran (%)c
Most favored 74.7 61.5 79.4 65.6 72.0
Additionally allowed 24.7 37.5 20.6 33.2 27.7
Generously allowed 0.6 1.0 0 1.2 0.3
Disallowed 0 0 0 0 0
α-helix hydrophobic moment
(μH) a,d
3.91 – 4.30 2.43 2.43
a α-helix residues are deﬁned as: Thr4–Lys16 for MIP-3α51–70, Trp5–Leu14 for IL-853–
72 , Pro4–Leu14 for NAP-250–70 and TC-150–68.
b Structures of the chemokine structures are from PDB as follows: 2HCI, MIP-3α ;
1IKL, IL-8; 1NAP, NAP-2 and TC-1 (a structure of TC-1 is not available).
c As determined by Laskowski et al. [47].
d Computed using the Totalizer module of MPEx (http://blanco.biomol.uci.edu/
mpex).
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structure for the 12-mer MIP-3α59–70 peptide is probably due to its
low α-helical propensity which is evidenced by the CD data (Fig. 1).
Statistics for the twenty ﬁnal NMR structures of each peptide are
listed in Table 3. Hydrophobic moments (μH) for the α-helical
portions of the 18–20-mer peptides are also reported and can be
used as estimates of α-helical amphipathicities. The long C-terminal
peptide structures show a well deﬁned α-helix of three to four turns
ﬂanked by poorly deﬁned ends. As is commonly observed, RMSDs for
the central helical regions, which span between nine to thirteen
residues, are considerably lower compared to those of the full length
peptides. The helical regions are well deﬁned by medium range NOE
distance restraints (i,i+2; i,i+3; i,i+4) that are classically associated
with α-helices (data not shown). In the intact chemokines, the
sidechains of the hydrophobic residues in the amphipathic α-helices
point towards the interior of the proteins while the charged residues
are solvent-exposed. The nonpolar solvent provides a similar
stabilizing environment for the hydrophobic portion of the helix
and it promotes the formation of a helix in the peptide.
MIP-3α51–70 has the longest stable α-helix (Fig. 2A), with the
Ramachandran plot showing the highest number of φ and ψ backbone
dihedral angles in the α-helical region (not shown). Its α-helix spans
four turns from Thr4 to Lys16 with a high degree of amphipathicity
(μH=3.91). Lys7, Arg11 and Lys15 make up the positively charged
side, which also includes the polar Ser14 sidechain. The hydrophobic
face consists of Trp5, Val6, Tyr8, Ile9, Val10, Leu12 and Leu13, but a
protruding Lys16 is also present. The unstructured ends ﬂanking the
α-helix are polar and have twomore positively charged residues, Lys2
and Lys18.
In contrast, the short peptide, MIP-3α59–70, does not form a stable
α-helix in SDS micelles (Fig. 2C). Particularly for the ﬁrst ﬁve amino
acid residues, there are only two medium range NOE peakscharacteristic of an α-helix conformation. The RMSD for the entire
backbone is 0.729 Å with the slightly higher deviations coming from
the end N- and C-terminal residues. MIP-3α59–70 is also amphipathic,
but unlike MIP-3α51–70, the division between the hydrophobic and
cationic regions is perpendicular to the length of the peptide. The N-
terminal side of the peptide is comprised of Ile1, Val2, Leu4 and Leu5,
while the C-terminal side includes the charged sidechains of Lys7,
Lys8, Lys10 and the polar end residues Gln11 and Met12.
Theα-helix of IL-853–72 is in agreement with the available solution
structure of intact IL-8 (Fig. 3) [65]. In the ensemble of ﬁnal peptide
structures, the helix is shorter than what has been previously
predicted by a homology and energy-based model [32]. The α-helix
is again amphipathic and Trp5, Val6, Val9, Val10, Phe13 and Leu14
contribute to the high hydrophobic moment (μH=4.30). The cationic
surface composed of Arg8, Lys 12 and Lys15 is somewhat neutralized
by the presence of Glu11. Similar to MIP-3α51–70, the ends of the
peptide are very polar, although they include mixtures of oppositely
charged sidechains, speciﬁcally Lys2 and Glu3 near the N-terminus
and Arg16 and Glu18 at the C-terminal side of the peptide.
The three-turn α-helices of NAP-250–70 and TC-150–68 contain the
same residues and are less amphipathic than the other peptides with
low hydrophobic moments of 2.43 (Fig. 4). The hydrophobic surface
encompasses fewer residues, speciﬁcally Ile6, Val10 and Leu14, and
these two peptides are devoid of aromatic residues. The positively
charged surface is more spread out, involving the Arg5, Lys8, Lys12
and Lys13 sidechains. The presence of Ile9 is mildly disruptive to this
cluster of positive charges. The variable ends of these peptides are
signiﬁcant especially because of the two-residue C-terminal extension
that distinguishes NAP-250–70 from TC-150–68, which is a critical
determinant for the antimicrobial activity in the parent chemokine
protein. Two long range distance restraints were observed in the
NOESY spectrum of NAP-250–70 between the amide proton of the last
residue, Asp21, and the δ and α protons of Lys12. Electrostatic
interactions between these residues bring four negatively charged
groups, Asp17, Glu18, Asp21 and the carboxyl terminus, from the C-
terminal region back over the central α-helix to partly mask the
positively charged surface. No correlations were found in the NOESY
spectrum for TC-150–68 between any of the C-terminal residues and
the central portion of its α-helix.3.5. Calcein leakage assays
The disruption of a cellular membrane caused by antimicrobial
peptides can be assayed by following the ﬂuorescence signal of
trapped calcein, a self-quenching dye at high concentrations, as it is
released from LUVs [50]. Two different lipid compositions were used
to make up the model membrane LUVs: equimolar amounts of
zwitterionic ePC and anionic ePG to represent bacterial membranes,
and a 2.5:1 ratio of ePC to cholesterol to represent mammalian
membranes (Fig. 5) [51].
With both lipid systems, MIP-3α51–70 was the strongest leakage-
inducing peptide. It caused exceptionally high amounts of intrave-
sicular release from ePC:ePG LUVs with 89.4±1.4% leakage at the low
P/L ratio of 1:50 (Fig. 5B). These results point to the bacterial
membrane as a major site of action for MIP-3α51–70, which has also
been demonstrated for other α-helical antimicrobial peptides such as
magainin [50] and cecropin [66]. Leakage from ePC:cholesterol LUVs
upon the addition of MIP-3α51–70 was much lower (26.3±3.5%
leakage at a P/L ratio of 1 to 10) compared to ePC:ePG LUVs. This
suggests that the peptide would be selective against bacterial
membranes over mammalian membranes. In sharp contrast, only
very low amounts of leakage were caused by the addition of MIP-
3α59–70, IL-853–72, NAP-250–70 and TC-150–68 from both LUV types.
Even at a high P/L ratio, leakage did not exceed 5% in either model
membrane system (Fig. 5B).
Fig. 2. Solution structures of MIP-3α51–70 in 4:4:1 CD3OH:CDCl3:H2O (A and B) and MIP-3α59–70 in SDS micelles (C and D). (A and C) Ribbon diagram of the ten lowest energy
structures, ﬁtted to the backbone atoms of the coreα-helix spanning Thr4-Lys16 for MIP-3α51–70 (RMSD 0.407 Å) and ﬁtted to the entire backbone for MIP-3α59–70 (RMSD 0.729 Å).
Hydrophobic sidechains are showcased in gray and positively charged sidechains in blue, with the right panels showing a representative structurewith a viewperpendicular to the left
panels. (B and D) Electrostatic surface plots showing opposite faces of the MIP-3α-derived peptides.
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The chemokine C-terminal peptides were assayed for bactericidal
activity using a standard microdilution technique (Table 4) [21,35].
The antimicrobial activities of MIP-3α51–70 have been reported
previously [20,35]. MIP-3α51–70 had high activity against all three
tested species, B. subtilis, S. aureus and E. coli. MIP-3α59–70, which
comprises of only the last 12 residues of the former peptide, was
comparatively poor as an antimicrobial and has lost most of the anti-
staphylococcal activity. IL-853–72 and NAP-250–70 had moderate and
low activity, respectively, against B. subtilis. TC-150–68 was not
bactericidal against any of the organisms. Hemolytic assays were
performed to assess the selectivity of the C-terminal peptides for
bacterial over mammalian cells (Fig. 6). MIP-3α51–70 was the only
peptide with signiﬁcant hemolytic activity, causing 50% lysis at a
concentration of 100 μM.
4. Discussion
Peptide fragments derived from intact proteins do not necessarily
preserve their native conformation. This has been most dramaticallydemonstrated by the spontaneous helix-to-sheet conversion of the
antimicrobial bovine lactoferricin peptide when it is released from
bovine lactoferrin [67,68]. Such observations reinforce the impor-
tance of the overall tertiary structure of proteins where hydrophobic
contacts with the remainder of the chemokine proteins stabilizes the
fold of the attached C-terminal helix. It also implies that a functional
peptide fragment may have altered structure and activity compared
to the parent protein [61,67]. Indeed the antimicrobial activity of the
bovine peptide lactoferricin far exceeds that of the intact protein
[69,70]. The C-terminal chemokine peptides studied here are
structurally similar to numerous antimicrobial α-helical peptides.
Although the activities of the peptides may match those of the parent
proteins as seems to be the case for MIP-3α51–70, their mode of action
may very well be distinct. This point is further illustrated with MIP-
3α59–70, which does not seem to be membrane-active like its longer
counterpart, but it is somewhat antimicrobial nonetheless.
The C-terminal chemokine peptides studied here were designed
with previous studies in mind that highlight the importance of this
portion of the proteins to their antimicrobial activity [20,21,31,32,71].
Here, we have experimentally determined the structures which can
be compared to computer-generated models for the IL-8 region
Fig. 3. Solution structure of IL-853-72 in 4:4:1 CD3OH:CDCl3:H2O. (A) Ribbon diagram of the ten lowest energy structures, ﬁtted to the backbone atoms of the core α-helix spanning
Trp5-Leu14 (RMSD 0.436 Å). Hydrophobic sidechains are showcased in gray, positively charged sidechains in blue, and negatively charged sidechains in red. The right panels show a
representative structure with a view perpendicular to the left panels. (B) Electrostatic surface plots showing opposite faces of the peptide.
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homology comparisons with protein structures. This approach is not
ideal because regions of secondary structure elements in proteins do
not necessarily fold by themselves in aqueous solution. Rather, their
formation depends on stabilizing long range tertiary protein structure
interactions or on solvent effects. The CD spectroscopy data presented
here clearly indicate that these ∼20-mer peptides are unstructured in
water and require an environment with some hydrophobicity to form
their regular amphipathic secondary structure. This generalization is
further supported by the AGADIR calculations, which rely on energy
contributions from only short range interactions to predict the α-
helical content of a monomeric peptide in aqueous solution [54,55].
Properties of α-helical antimicrobial peptides have been investi-
gated by many groups to aid in the design of successful peptide drug
candidates to replace conventional antibiotics. Helical stability and
amphipathicity up to optimal degrees promote higher activity [72–74].
However, if the peptide becomes too hydrophobic, the positive charges
of a peptide are overshadowed and functional selectivity is lost as the
peptide gains cytotoxicity in addition to antimicrobial activity. The
high-resolution structures of MIP-3α51–70, IL-853–72, NAP-250–70, and
TC-150–68 in membrane mimetic solvent show well deﬁned α-helices
of differing properties which can be used to compare their activities.
Compared to the other peptides, MIP-3α51–70 is the most active
peptide. It efﬁciently induces leakage from vesicles with negatively
charged lipid headgroups. This behaviour has been commonly
associated with the toroidal pore mechanism of action in which
pores are formed in the cytoplasmic membrane that are lined with
peptides and interdigitating lipid molecules [75,50], although other
mechanisms of membrane permeabilization such as the carpet and
sinking raft models cannot be excluded [75,76]. The high activity of
MIP-3α51–70 also extends to cytotoxicity, with modest levels of
leakage observed for the PC/cholesterol vesicles at the low lipid to
peptide ratio and signiﬁcant hemolytic activity. The cytotoxicity is not
present in intact MIP-3α where the hydrophobic portion of the α-
helix is part of the interior of the chemokine. Thus, there can be
potential disadvantages when amphipathic peptide fragments are
isolated from intact proteins. Nevertheless, the effective hemolytic
concentration of MIP-3α51–70 is at least 50-fold greater than the
antimicrobial lethal dose concentrations.
Although the shorter MIP-3α59–70 peptide is not as potent as MIP-
3α51–70, it still has signiﬁcant activity against B. subtilis and E. coli.
Unlike MIP-3α51–70, MIP-3α59–70 does not cause intravesicularleakage from the calcein assays and therefore is not expected to be
membrane-active. Its low propensity to form an α-helix in a
membranous environment can be attributed to its short length.
Furthermore, its sequence starts at Ile59 of MIP3-α and in the native
chemokine the α-helix begins at Thr54. The resulting NMR structure
of this shorter peptide in SDSmicelles shows that its amphipathicity is
not aligned along the α-helix axis. Thus, the peptide would not be
expected to orient itself parallel to the surface of a bacterial
membrane, which has been observed with many α-helical antimi-
crobial peptides that are associated with the toroidal pore or carpet
mechanisms of membrane disruption [77]. The biological activity of
MIP-3α59–70 is probably due to intracellular interactions following
peptide translocation across the membrane [23]. This has generally
been found for short peptides as small as six residues [78,79]. Possible
inhibition of intracellular functions may stem from some of the
peptides' abilities to bind DNA [80,81], although binding to RNA and
important proteins cannot be ruled out either.
The positive charges of the IL-853–72 amphipathic α-helix are in
part neutralized by the anionic sidechain of Glu11. The entire peptide
has a low overall net charge of +2 with additional negatively charged
residues at both ends, which are likely responsible for its low
membrane-perturbing ability and limited antimicrobial activity.
There are discrepancies between the antimicrobial data reported
here for IL-853–72 and previous studies of the same peptide. Under our
experimental conditions, it was moderately active against B. subtilis
and inactive against S. aureus and E. coli. In solid phase inhibition zone
area assays, Bjorstad et al. [31] report high growth inhibition of the
same peptide against E. coli and no activity with B. subtilis and S.
aureus and interestingly, the intact IL-8 chemokine has no anti-E. coli
activity. In another study, a peptide of the same sequence with the
exception of the N-terminal Pro residue was assayed for antimicrobial
activity in various media [32]. In solution phase assays, this peptide
has no activity against S. aureus and E. coli in agreement with the data
listed here, but high anti-E. coli activity was found in blood plasma,
serum and whole blood [32]. This difference may be explained by
differences in experimental conditions and by the fact that other
bacterial strains of the indicated species were used.
As indicated by their low hydrophobic moments, the NAP-250–70
and TC-150–68 α-helices are not greatly amphipathic and are much
less hydrophobic than the MIP-3α- and IL-8-derived peptides.
However, the C-terminal tail of NAP-250–70 folds back over part of
the α-helix, resulting in less solvent-exposed cationicity compared to
Fig. 4. Solution structures of NAP-250–70 (A and B) and TC-150–68 (C and D) in 4:4:1 CD3OH:CDCl3:H2O. (A and C) Ribbon diagram of the ten lowest energy structures, ﬁtted to the
backbone atoms of the core α-helices spanning Pro4-Leu14 (RMSD 0.364 Å for NAP-250–70 and 0.449 Å for TC-150–68). Hydrophobic sidechains are in gray, positively charged
sidechains in blue, and negatively charged sidechains in red. The right panels show representative structures with a view perpendicular to the left panels. (B and D) Electrostatic
surface plots showing opposite faces of the peptides.
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shown by the calcein leakage results and they also lacked antimicro-
bial activity. The negative charges at the unstructured ends of both
peptides may also contribute to this lack of activity, especially in view
of the fact that the α-helix itself is very cationic with ﬁve Arg/Lys
residues. The ends of dermaseptin S9 and lactoferrampin, two
recently characterized antimicrobial peptides, have also been shown
to play a critical role in their activity [26,82]. The α-helix of the
dermaseptin S9 peptide is highly hydrophobic and not amphipathic,
but both ends are polar and positively charged. This gives the peptide
high antimicrobial potency and low hemolytic activity [82]. Likewise,
it was found for lactoferrampin that a relatively uncharged amphi-
pathic helix needed to be followed by a ﬂexible highly positively
charged region to make it antimicrobial [25,26]. In the case of NAP-
250–70, the multiple anionic residues on the ends presumably
neutralize some of the favorable interactions between the core α-
helix and anionic bacterial membranes.
An examination of the overall NAP-2 protein structure helps to
understand how its antimicrobial activity may increase when its lasttwo residues are cleaved off to become TC-1 (Fig. 7). The electrostatic
potential plot indicates that, although there are positively and
negatively charged residues scattered throughout the chemokine
surface, the protein is somewhat amphipathic. A strong concentration
of cationic charges is observed in the region encompassing the N-
terminal region and the C-terminal α-helical domain located in its
vicinity, while the remainder of the protein surface is relatively
hydrophobic. This positive patch is comprised mostly of residues from
the C-terminal α-helix, speciﬁcally Arg54, Lys56, Lys57, Lys 60 and
Lys61, however Lys17 from the N-terminal portion and Lys41 in the
turn between β-strands 2 and 3 also contribute to the positively
charged surface region. In the NAP-250–70 and TC-150–68 peptides
studied here, Lys17 and Lys41 are not included which may help to
explain why they do not exhibit antimicrobial activities. The crystal
structure of NAP-2 displays poor electron density for the C-terminal
end and as such, only reasonable deﬁnition is seen up to Asp66 (Fig. 7)
[83]. This ﬂexibility has been observed by an NMR dynamics study as
well [84]. The ﬁnal four residues of NAP-2 include two more anionic
residues in addition to the charged carboxy-terminus. This stretch of
Fig. 5. (A) Calcein leakage caused by the α-helical chemokine peptides from LUVs
composed of 1:1 ePC:ePG 2.5:1 ePC:cholesterol at 1:10 peptide:lipid. (B) Calcein
leakage proﬁles of the higher leaking peptides, MIP-3α51–70 (black) and IL-853-72
(grey), from ePC:ePG (solid) and ePC:cholesterol (dotted) LUVs at different peptide:
lipid ratios. Experiments were performed in triplicate at 37 °C.
Fig. 6. Hemolytic activities of the α-helical chemokine peptides. Peptide mixtures with
humanRBCswere incubated for 60min at 37 °C. The peptides are as follows:MIP-3α51–70,
solid black; IL-853–72, long dashes; NAP-250–70, solid gray; TC-150–68, gray short dashes.
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charged patch of NAP-2 and prevent it from being antimicrobial. The
removal of Asp71 in TC-1might stop this region from folding back and
could be sufﬁcient to give high antimicrobial potency to the truncated
protein.
In conclusion, we have determined the solution structures,
membrane perturbation characteristics and antimicrobial activities
of a number of carboxy-terminal peptides derived from human
chemokines of different microbicidal potencies. We compared three
different situations. In the case of MIP-3α, both the protein and the C-
terminal helical peptide are known to be active. For IL-8, only the
carboxy-terminal peptide shows activity, but not the intact protein.
For NAP-2 and TC-1, truncation of the C-terminal end of the protein
gives rise to antimicrobial activity. Of all the peptides studied here,
MIP-3α51–70 shows considerable promise for use as an anti-infective
agent given its potent biological activities which are due to the
strongly cationic α-helix that forms upon membrane binding. MIP-
3α59–70, lacking eight of MIP-3α51–70's twenty residues, is less
antimicrobial and has a structure and mechanism of action that is
distinct from its longer counterpart. IL-853–72 folds into an amphi-
pathic α-helix under the same conditions, but the lower overall net
charge results in a less potent peptide. Further removal of these
negative charges could increase the potency of this IL-8 peptide as weTable 4
Antimicrobial activities of the C-terminal chemokine peptides.
Peptide LD99.9 (μM)
B. subtilis S. aureus E. coli
MIP-3α51–70 ≤0.45 1.9 ≤0.45
MIP-3α59–70 15 120 30
IL-853–72 15 N120 N120
NAP-250–70 120 N120 N120
TC-150–68 N120 N120 N120have demonstrated for the human lactoferrampin peptide [26]. Theα-
helices of NAP-250–70 and TC-150–68 as induced by the membrane-
mimetic cosolvent are less amphipathic and their anionic ends renderFig. 7. NAP-2-derived peptides mapped on the NAP-2 crystal structure (PDB 1NAP). (A)
Ribbon representation of NAP-250–70 (green) structure solved in membrane mimetic
solvent ﬁtted onto NAP-2 through the α-helix. (B) Electrostatic surface plot of NAP-2
with basic residues of the cationic patch highlighted (Lys60 not shown in this view). The
last four residues, Glu68–Ser69–Ala70–Asp71, are not included in the crystal structure
as they were not identiﬁed by the electron density, but they are represented by the pink
circle.
1071L.T. Nguyen et al. / Biochimica et Biophysica Acta 1798 (2010) 1062–1072the peptides inactive against bacteria, especially for NAP-250–70 where
the C-terminal tail was found to fold back to neutralize part of the
positively charged portion of its helix.
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